Waters Net Profit Margin 2010-2025 | WAT
Current and historical net profit margin for Waters (WAT) from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue. Waters net profit margin for the three months ending June 30, 2025 was .
| Waters Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2025-06-30 | $3.05B | $0.66B | 21.70% |
| 2025-03-31 | $2.98B | $0.66B | 22.02% |
| 2024-12-31 | $2.96B | $0.64B | 21.56% |
| 2024-09-30 | $2.91B | $0.62B | 21.45% |
| 2024-06-30 | $2.88B | $0.60B | 20.72% |
| 2024-03-31 | $2.91B | $0.60B | 20.76% |
| 2023-12-31 | $2.96B | $0.64B | 21.75% |
| 2023-09-30 | $3.00B | $0.65B | 21.82% |
| 2023-06-30 | $2.99B | $0.68B | 22.55% |
| 2023-03-31 | $2.97B | $0.69B | 23.22% |
| 2022-12-31 | $2.97B | $0.71B | 23.81% |
| 2022-09-30 | $2.95B | $0.70B | 23.63% |
| 2022-06-30 | $2.90B | $0.70B | 24.21% |
| 2022-03-31 | $2.87B | $0.70B | 24.55% |
| 2021-12-31 | $2.79B | $0.69B | 24.84% |
| 2021-09-30 | $2.74B | $0.69B | 25.36% |
| 2021-06-30 | $2.67B | $0.66B | 24.70% |
| 2021-03-31 | $2.51B | $0.62B | 24.54% |
| 2020-12-31 | $2.37B | $0.52B | 22.06% |
| 2020-09-30 | $2.30B | $0.51B | 22.00% |
| 2020-06-30 | $2.28B | $0.52B | 22.65% |
| 2020-03-31 | $2.36B | $0.54B | 22.78% |
| 2019-12-31 | $2.41B | $0.59B | 24.61% |
| 2019-09-30 | $2.41B | $0.58B | 23.95% |
| 2019-06-30 | $2.41B | $0.58B | 24.06% |
| 2019-03-31 | $2.40B | $0.59B | 24.59% |
| 2018-12-31 | $2.42B | $0.59B | 24.55% |
| 2018-09-30 | $2.39B | $0.06B | 2.34% |
| 2018-06-30 | $2.38B | $0.05B | 2.14% |
| 2018-03-31 | $2.34B | $0.03B | 1.15% |
| 2017-12-31 | $2.31B | $0.02B | 0.91% |
| 2017-09-30 | $2.25B | $0.55B | 24.34% |
| 2017-06-30 | $2.21B | $0.54B | 24.28% |
| 2017-03-31 | $2.19B | $0.53B | 24.33% |
| 2016-12-31 | $2.17B | $0.52B | 24.03% |
| 2016-09-30 | $2.13B | $0.50B | 23.42% |
| 2016-06-30 | $2.10B | $0.49B | 23.29% |
| 2016-03-31 | $2.06B | $0.47B | 22.69% |
| 2015-12-31 | $2.04B | $0.47B | 22.96% |
| 2015-09-30 | $2.04B | $0.47B | 22.99% |
| 2015-06-30 | $2.03B | $0.47B | 22.93% |
| 2015-03-31 | $2.02B | $0.46B | 22.63% |
| 2014-12-31 | $1.99B | $0.43B | 21.66% |
| 2014-09-30 | $1.97B | $0.42B | 21.41% |
| 2014-06-30 | $1.94B | $0.41B | 21.03% |
| 2014-03-31 | $1.90B | $0.40B | 20.96% |
| 2013-12-31 | $1.90B | $0.45B | 23.65% |
| 2013-09-30 | $1.86B | $0.48B | 26.02% |
| 2013-06-30 | $1.85B | $0.49B | 26.17% |
| 2013-03-31 | $1.85B | $0.49B | 26.66% |
| 2012-12-31 | $1.84B | $0.46B | 25.07% |
| 2012-09-30 | $1.84B | $0.42B | 22.96% |
| 2012-06-30 | $1.85B | $0.43B | 23.01% |
| 2012-03-31 | $1.84B | $0.43B | 23.16% |
| 2011-12-31 | $1.85B | $0.43B | 23.33% |
| 2011-09-30 | $1.82B | $0.42B | 23.25% |
| 2011-06-30 | $1.76B | $0.42B | 23.62% |
| 2011-03-31 | $1.70B | $0.40B | 23.53% |
| 2010-12-31 | $1.64B | $0.38B | 23.30% |
| 2010-09-30 | $1.59B | $0.36B | 22.66% |
| 2010-06-30 | $1.56B | $0.34B | 21.83% |
| 2010-03-31 | $1.53B | $0.33B | 21.25% |
| 2009-12-31 | $1.50B | $0.32B | 21.55% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $17.538B | $2.958B |
| Waters Corp. is an analytical instrument manufacturer and offers practical and sustainable products for laboratory-dependent organizations. Moreover, Waters provides analytical workflow solutions based on mass spectrometry (MS), liquid chromatography (LC) and thermal analysis technologies. The company's products are used by pharmaceutical, life science, biochemical, industrial, academic and government customers, working in research and development, quality assurance and other laboratory applications. The company operates in Asia, Americas and Europe. Waters organizes its business into two operating segments: Waters Division and TA Division. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $184.320B | 22.30 |
| Intuitive Surgical (ISRG) | United States | $168.896B | 70.01 |
| IDEXX Laboratories (IDXX) | United States | $51.272B | 53.36 |
| Edwards Lifesciences (EW) | United States | $47.496B | 31.48 |
| Alcon (ALC) | Switzerland | $40.130B | 26.94 |
| IQVIA Holdings (IQV) | United States | $32.096B | 18.14 |
| DexCom (DXCM) | United States | $29.953B | 44.93 |
| Mettler-Toledo (MTD) | United States | $26.475B | 31.42 |
| STERIS (STE) | Ireland | $24.522B | 26.10 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.006B | 0.00 |
| Hologic (HOLX) | United States | $14.842B | 16.08 |
| Penumbra (PEN) | United States | $10.410B | 76.05 |
| Globus Medical (GMED) | United States | $8.307B | 19.16 |
| Sysmex ADR (SSMXY) | Japan | $8.057B | 25.60 |
| Masimo (MASI) | United States | $7.741B | 26.05 |
| Teleflex (TFX) | United States | $5.723B | 9.24 |
| Glaukos (GKOS) | United States | $5.455B | 0.00 |
| TransMedics (TMDX) | United States | $4.002B | 60.82 |
| Integer Holdings (ITGR) | United States | $3.786B | 18.89 |
| LivaNova (LIVN) | United Kingdom | $3.084B | 17.65 |
| Alphatec Holdings (ATEC) | United States | $2.394B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $2.270B | 0.00 |
| Veracyte (VCYT) | United States | $2.251B | 31.10 |
| Artivion (AORT) | United States | $2.064B | 104.14 |
| Nihon Kohden (NHNKY) | Japan | $1.907B | 22.76 |
| Elekta AB (EKTAY) | Sweden | $1.887B | 17.66 |
| Integra LifeSciences Holdings (IART) | United States | $1.159B | 6.64 |
| OPKO Health (OPK) | United States | $1.127B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.066B | 0.00 |
| IRadimed (IRMD) | United States | $0.939B | 45.59 |
| Tandem Diabetes Care (TNDM) | United States | $0.828B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.825B | 0.00 |
| AxoGen (AXGN) | United States | $0.743B | 0.00 |
| SiBone (SIBN) | United States | $0.716B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.586B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.551B | 9.73 |
| OrthoPediatrics (KIDS) | United States | $0.542B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.469B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.452B | 3.63 |
| AngioDynamics (ANGO) | United States | $0.407B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.399B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.383B | 91.17 |
| Mesa Laboratories (MLAB) | United States | $0.378B | 9.62 |
| RxSight (RXST) | United States | $0.350B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.302B | 0.00 |
| NeuroPace (NPCE) | United States | $0.294B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.293B | 20.23 |
| Spectral Diagnostics (EDTXF) | Canada | $0.293B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.286B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.229B | 0.00 |
| 908 Devices (MASS) | United States | $0.226B | 0.00 |
| Neuronetics (STIM) | United States | $0.222B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.222B | 0.00 |
| Inogen (INGN) | United States | $0.214B | 0.00 |
| CVRx (CVRX) | United States | $0.198B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.185B | 0.00 |
| Accuray (ARAY) | United States | $0.177B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.150B | 0.00 |
| LENSAR (LNSR) | United States | $0.145B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.137B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.132B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.113B | 0.00 |
| InspireMD (NSPR) | United States | $0.102B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.098B | 0.00 |
| Hyperfine (HYPR) | United States | $0.097B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.088B | 0.00 | |
| QT Imaging Holdings (QTIH) | United States | $0.071B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.059B | 0.00 |
| Spectral AI (MDAI) | United States | $0.056B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.052B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.039B | 0.00 |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| Envoy Medical (COCH) | United States | $0.025B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.025B | 0.00 |
| DarioHealth (DRIO) | United States | $0.022B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| Tenon Medical (TNON) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.007B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.31 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |